Additionally, histopathological analysis demonstrated that ACE2 activation via diminazene (DIZE) downregulated FAK expression in pulmonary arterioles and promoted pulmonary artery smooth muscle cell apoptosis, leading to the alleviation of PAH [30]. The gene discussed is ACE2; the disease is pulmonary arterial hypertension.